CV Sciences targets profitability with new product lines and M&A strategy in 2025
Q4 2024 Management View CEO Joseph Dowling highlighted the company’s focus on scaling its business, achieving cost efficiencies, and transitioning to a global health and wellness company. He noted a ...
vegconomist4d
CV Sciences Expands Plant-Based Portfolio with Launch of Lunar Fox Food Co.
CV Sciences, Inc. has launched a new plant-based food line under the brand name Lunar Fox Food Co. The product range offers a ...
Q4 2024 CV Sciences Inc Earnings Call
Greetings and welcome to the CV Sciences fourth quarter and year end, 2024 financial results conference call. At this time, all participants are in a listen-only mode. A brief question-and-answer ...
Morningstar5d
CV Sciences, Inc. Reports Fiscal Year-End 2024 Financial Results
SAN DIEGO, CA / ACCESS Newswire / March 27, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness ...
Investing5d
Earnings call transcript: CV Sciences Q4 2024 sees steady revenue, strategic shifts
CV Sciences Inc. (CVSI) reported its financial results for the fourth quarter and full year of 2024, showing steady revenue figures and strategic operational shifts. The company’s revenue for the year ...
Insider Monkey4d
CV Sciences, Inc. (PNK:CVSI) Q4 2024 Earnings Call Transcript
Operator: Greetings. Welcome to the CV Sciences Fourth Quarter and Year End 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A brief question and ...
Seeking Alpha5d
CV Sciences, Inc. (CVSI) Q4 2024 Earnings Call Transcript
Greetings and welcome to the CV Sciences’ Fourth Quarter and Year-End 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A brief question-and ...